Incorporation of recombinant gamma interferon into liposomes enhances its ability to induce peritoneal macrophage antitoxoplasma activity.

Infection and Immunity
J W MellorsJ L Ryan

Abstract

In this study we compared the ability of free- and liposome-incorporated murine recombinant gamma interferon (rIFN-gamma) to enhance peritoneal macrophage H2O2 release and antitoxoplasma activity in vitro. rIFN-gamma was efficiently (37 to 47%) incorporated into multilamellar vesicles composed of phosphatidylglycerol/cholesterol in a 2:1 molar ratio. The amount of rIFN-gamma incorporated into multilamellar vesicles and added to macrophages (0.1 to 1,000 U/ml) was quantitated with [3H]rIFN-gamma. The concentration of liposomal rIFN-gamma required to enhance macrophage H2O2 release (1 U/ml) and maximally inhibit Toxoplasma gondii growth (10 U/ml) was one-tenth the concentration required for free rIFN-gamma (10 and 100 U/ml, respectively). This increase in potency was observed in both thioglycolate-elicited and resident peritoneal macrophages. Control liposomes containing encapsulated buffer had no effect on the potency of free rIFN-gamma. The duration of macrophage activation induced by 24 h of liposomal rIFN-gamma treatment was also considerably longer than that induced by free rIFN-gamma (2 days versus less than 1 day). These data indicate that liposomal rIFN-gamma is more active than free rIFN-gamma as an inducer of macrophage...Continue Reading

References

Aug 1, 1977·The Journal of protozoology·E R Pfefferkorn, L C Pfefferkorn
Jun 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·C R AlvingW L Hanson
Oct 8, 1987·The New England Journal of Medicine·C A Dinarello, J W Mier
Feb 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S Vadhan-RajS E Krown
Jan 1, 1988·The Journal of Infectious Diseases·B J Luft, J S Remington
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·D A EppsteinA B Schreiber
Mar 24, 1988·The New England Journal of Medicine·R B Johnston
May 1, 1987·Antimicrobial Agents and Chemotherapy·G Lopez-Berestein
Jan 1, 1986·Advances in Experimental Medicine and Biology·R Kirsh, G Poste
May 1, 1987·The American Journal of Medicine·H W Haverkos
Jul 1, 1983·The Journal of Clinical Investigation·E S KleinermanI J Fidler
Feb 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·E R Pfefferkorn
Mar 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·I J FidlerZ L Barnes

❮ Previous
Next ❯

Citations

Jan 1, 1994·Journal of Drug Targeting·I A Bakker-WoudenbergM C Woodle
Feb 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C S Subauste, J S Remington
May 10, 2017·Parasitology Research·João Paulo AssoliniIdessania Nazareth Costa
Jan 1, 1991·Biotherapy·G StormD J Crommelin
Jan 27, 1995·Pharmacy World & Science : PWS·J J BergersI A Bakker-Woudenberg
Jan 1, 1994·Antimicrobial Agents and Chemotherapy·E R Pfefferkorn, S E Borotz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.